Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease.

The risk of idiopathic pneumonia syndrome (IPS) in patients with Hodgkin's disease (HD) undergoing high-dose chemotherapy (HDC) is significant, and once developed IPS is potentially fatal. The aim of this study was to quantify this risk accurately and determine prognostic factors for its develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubio, C., Hill, M. E., Milan, S., O'Brien, M. E., Cunningham, D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222758/
https://www.ncbi.nlm.nih.gov/pubmed/9083341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222758/
https://www.ncbi.nlm.nih.gov/pubmed/9083341

Ejemplares similares